Syntegon Pharma Technology is pleased to announce that Alex Trombley has joined our team as a Business Development and Process Specialist supporting our pharmaceutical oral solid dosage product line (Huettlin) in North America.
Alex graduated with a degree in Chemical Engineering from the University of Michigan. He has 5 years of experience in oral solid dosage formulation and process development with Eli Lilly. During his time with Eli Lilly, he was responsible for early phase formulation definition/manufacturing platform selection as well as late stage process development, scale-up, technology transfer, and control strategy definition.
Alex is excited about his new role and joining the Syntegon team and hopes to leverage his industry experience to best serve North American customer’s needs.
